Plant cell cultures represent a potential method for the large-scale production of important secondary metabolites. One significant example is the anti-cancer agent paclitaxel, a secondary metabolite produced by Taxus. Paclitaxel is a member of a family of related compounds known as taxanes. In Taxus suspension cultures, paclitaxel is often less than 10% of the total taxanes present. This low selectivity represents an excellent opportunity to increase overall accumulation through targeted metabolic engineering. We are focusing on the use of molecular approaches to delineate global metabolic control of paclitaxel accumulation in Taxus cell cultures. We are taking a two-pronged approach in identifying key regulatory genes. First, we have investigated expression of known pathway genes through Northern analysis, PCR and metabolite analysis via HPLC. Second, we have applied a novel systems-wide transcript profiling method to identify both up- and down-regulated genes upon induced paclitaxel accumulation. These genes may not be involved in paclitaxel biosynthesis, but rather transcriptional regulation, transport, secretion and degradation. This talk will highlight our research-to-date with an emphasis on novel approaches for profiling genetically uncharacterized systems.
See more of #196 - Advances in Metabolic Engineering and Bioinformatics: From Prokaryotes to Eukaryotes (15C06)
See more of Food, Pharmaceutical & Bioengineering Division
See more of The 2005 Annual Meeting (Cincinnati, OH)